Seagen (NASDAQ:SGEN – Get Rating) had its target price raised by Oppenheimer from $160.00 to $208.00 in a report published on Tuesday morning, The Fly reports. Oppenheimer currently has an outperform rating on the biotechnology company’s stock. A number of other analysts also recently weighed in on the company. JMP Securities reiterated a buy rating […]
